glp 1 drugs and blindness Doctors are tracking rare reports of vision loss alongside accelerated facial aging caused by rapid weight loss from GLP-1 medications. MORE BELOW ⬇️ Complete Guide to GLP-1 Medications

In a randomized placebo-controlled trial in 310 healthy adults under 50 years of age, those given a supplement providing 900 mg EPA plus 360 mg DHA per day for 26 weeks had greater improvements on all but one test of speed and accuracy of memory than those given 900 DHA plus 270 mg EPA or placebo

Similarly, combining RSV with PPR improves cerebral blood flow and oxygen utilization, thereby boosting therapeutic efficacy in neurological conditions (10)

Content contributed by the Alzheimers Association A glucagon-like peptide-1 (GLP-1) drug appears to slow cognitive decline by protecting the brain, according to Phase 2b clinical trial data reported recently at the Alzheimers Association International Conference (AAIC) 2024, in Philadelphia and online

Wholesale Brain and Nerve Health These savings are a no-brainer